This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
27 Dec 2025

Hepaphagen-BFS Glycyrrhizine, Glycine, L-cysteine hydrochloride

- Used in the treatment of chronic hepatitis. Prevent the development of hepatocellular carcinoma in patients with chronic hepatitis C.- Eczema or dermatitis, urticaria, pruritus, rash due to drug or poisoning, tingling disease or stomatitis.

CompositionEach ml contains:Glycyrrhizine 2mg (as Glycyrrhizinate ammonium)Glycine 20mgL-cysteine hydrochloride 1mg (as L-cysteine hydrochloride monohydrate)Ampoule 5ml

Dosage Form
Solution for injection

Indication
- Used in the treatment of chronic hepatitis. Prevent the development of hepatocellular carcinoma in patients with chronic hepatitis C.
- Eczema or dermatitis, urticaria, pruritus, rash due to drug or poisoning, tingling disease or stomatitis.

Dosage Adminstration
Drugs used intravenously. Use as directed by doctors.Adults:Usual dose: Inject 5-20ml once a day. The dosage may be adjusted depending on the age and symptoms of the patient.Patients with hepatitis:Inject or infuse 40-60 ml once a day. The dosage may be adjusted depending on the age and symptoms of the patient. The maximum daily dose should not exceed 100ml / day.Pediatric patients:There are no adequate and well-controlled studies on pediatric patients. Not recommended for this group.Elderly patients:Elderly patients tend to have hypokalemia. Therefore, the patient's drug use should be closely monitored.Use for pregnant and lactating women:There are no adequate and well-controlled studies on pediatric patients. Do not use for these objects.

Mentioned Companies
Ha Noi CPC1 Pharmaceutical Joint Stock Company
View company profile